8,200 Shares in Misonix, Inc. (NASDAQ:MSON) Purchased by WealthTrust Axiom LLC

Share on StockTwits

WealthTrust Axiom LLC bought a new position in Misonix, Inc. (NASDAQ:MSON) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 8,200 shares of the medical equipment provider’s stock, valued at approximately $208,000. WealthTrust Axiom LLC owned about 0.09% of Misonix at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Geode Capital Management LLC raised its holdings in shares of Misonix by 5.3% in the 4th quarter. Geode Capital Management LLC now owns 35,095 shares of the medical equipment provider’s stock worth $561,000 after acquiring an additional 1,775 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Misonix by 95.3% in the 1st quarter. Acadian Asset Management LLC now owns 18,558 shares of the medical equipment provider’s stock worth $357,000 after acquiring an additional 9,054 shares during the last quarter. Rathbone Brothers plc raised its holdings in shares of Misonix by 6.2% in the 1st quarter. Rathbone Brothers plc now owns 15,500 shares of the medical equipment provider’s stock worth $298,000 after acquiring an additional 900 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of Misonix by 6.2% in the 2nd quarter. Wells Fargo & Company MN now owns 12,369 shares of the medical equipment provider’s stock worth $313,000 after acquiring an additional 724 shares during the last quarter. Finally, JPMorgan Chase & Co. acquired a new stake in shares of Misonix in the 2nd quarter worth about $49,000. Institutional investors own 25.89% of the company’s stock.

NASDAQ:MSON traded down $0.48 on Tuesday, hitting $20.06. The stock had a trading volume of 201 shares, compared to its average volume of 46,963. Misonix, Inc. has a 1 year low of $13.19 and a 1 year high of $27.54. The firm’s fifty day simple moving average is $22.74 and its two-hundred day simple moving average is $21.11.

Several equities research analysts have commented on MSON shares. BTIG Research reiterated a “buy” rating and issued a $27.00 price objective on shares of Misonix in a research note on Thursday, August 15th. TheStreet lowered shares of Misonix from a “c-” rating to a “d” rating in a research note on Thursday, June 20th. ValuEngine lowered shares of Misonix from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Canaccord Genuity reiterated a “buy” rating and issued a $30.00 price objective (up previously from $24.00) on shares of Misonix in a research note on Thursday, August 15th. Finally, BidaskClub upgraded shares of Misonix from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, July 3rd. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $28.33.

Misonix Company Profile

Misonix, Inc, together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells.

Further Reading: What is a back-end load?

Want to see what other hedge funds are holding MSON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Misonix, Inc. (NASDAQ:MSON).

Institutional Ownership by Quarter for Misonix (NASDAQ:MSON)

Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.